image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9410737_Fig4_384161.jpg | What can you see in this picture? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384153.jpg | What is being portrayed in this visual content? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384156.jpg | What stands out most in this visual? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384154.jpg | What is the principal component of this image? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384151.jpg | What is the central feature of this picture? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384159.jpg | What is the principal component of this image? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384162.jpg | What is the main focus of this visual representation? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410737_Fig4_384144.jpg | What is the core subject represented in this visual? | Examples of heatmaps generated by CLA-HDM for each etiology of unexplained CLA. When ultrasound BUS and CDFI images of a case (first row) are input into CLA-HDM, it will firstly give first-level diagnostic heatmaps to distinguish benign from malignant CLA (second row) and then second-level diagnostic heatmaps to identi... |
PMC9410761_f3_384166.jpg | What is the dominant medical problem in this image? | Transvaginal needle placement with the detachable puncture bracket. (A, B) Schematic diagrams of the pelvic cavity comparing the length of paths of transvaginal and perineal needle insertion; (C–F) Positron emission tomography/computed tomography (CT) shows recurrent lesions adjacent to the right ureter in the pelvic r... |
PMC9410761_f3_384165.jpg | What key item or scene is captured in this photo? | Transvaginal needle placement with the detachable puncture bracket. (A, B) Schematic diagrams of the pelvic cavity comparing the length of paths of transvaginal and perineal needle insertion; (C–F) Positron emission tomography/computed tomography (CT) shows recurrent lesions adjacent to the right ureter in the pelvic r... |
PMC9410761_f3_384171.jpg | What's the most prominent thing you notice in this picture? | Transvaginal needle placement with the detachable puncture bracket. (A, B) Schematic diagrams of the pelvic cavity comparing the length of paths of transvaginal and perineal needle insertion; (C–F) Positron emission tomography/computed tomography (CT) shows recurrent lesions adjacent to the right ureter in the pelvic r... |
PMC9410761_f3_384168.jpg | What is the core subject represented in this visual? | Transvaginal needle placement with the detachable puncture bracket. (A, B) Schematic diagrams of the pelvic cavity comparing the length of paths of transvaginal and perineal needle insertion; (C–F) Positron emission tomography/computed tomography (CT) shows recurrent lesions adjacent to the right ureter in the pelvic r... |
PMC9410761_f3_384167.jpg | What does this image primarily show? | Transvaginal needle placement with the detachable puncture bracket. (A, B) Schematic diagrams of the pelvic cavity comparing the length of paths of transvaginal and perineal needle insertion; (C–F) Positron emission tomography/computed tomography (CT) shows recurrent lesions adjacent to the right ureter in the pelvic r... |
PMC9410772_F1_384193.jpg | Describe the main subject of this image. | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384174.jpg | What key item or scene is captured in this photo? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384190.jpg | What's the most prominent thing you notice in this picture? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384183.jpg | What's the most prominent thing you notice in this picture? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384189.jpg | What is the focal point of this photograph? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384175.jpg | What is the dominant medical problem in this image? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384181.jpg | What is the central feature of this picture? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384194.jpg | What can you see in this picture? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384179.jpg | What key item or scene is captured in this photo? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384188.jpg | What is the main focus of this visual representation? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384180.jpg | What's the most prominent thing you notice in this picture? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384184.jpg | Can you identify the primary element in this image? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384173.jpg | What is being portrayed in this visual content? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384178.jpg | What can you see in this picture? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384176.jpg | Can you identify the primary element in this image? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384185.jpg | Describe the main subject of this image. | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384196.jpg | What is the focal point of this photograph? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384177.jpg | What stands out most in this visual? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384192.jpg | What is the principal component of this image? | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F1_384195.jpg | Describe the main subject of this image. | CLSM images of triple-labeled immunohistochemistry for CALB, SP, and CB1R in coronal sections containing the basal ganglia. a–f, Pseudocolor images consist of CALB (green), SP (blue), and CB1R (red) immunoreactivities, which are shown separately in the right panel. Arrows, arrowheads, and crossed arrows indicate lSP/hC... |
PMC9410772_F3_384199.jpg | What is the principal component of this image? | Analysis of contrasting immunoreactivities for SP and CB1R in the EPN. a, The procedures to measure the gray values of immunoreactivities for SP and CB1R. The dual-label image (1) is split into two singe-channel images (2), which are overlaid with a grid (3). The frames to be analyzed are selected according to the syst... |
PMC9410772_F3_384202.jpg | What can you see in this picture? | Analysis of contrasting immunoreactivities for SP and CB1R in the EPN. a, The procedures to measure the gray values of immunoreactivities for SP and CB1R. The dual-label image (1) is split into two singe-channel images (2), which are overlaid with a grid (3). The frames to be analyzed are selected according to the syst... |
PMC9410772_F3_384201.jpg | What is the main focus of this visual representation? | Analysis of contrasting immunoreactivities for SP and CB1R in the EPN. a, The procedures to measure the gray values of immunoreactivities for SP and CB1R. The dual-label image (1) is split into two singe-channel images (2), which are overlaid with a grid (3). The frames to be analyzed are selected according to the syst... |
PMC9410772_F3_384198.jpg | What can you see in this picture? | Analysis of contrasting immunoreactivities for SP and CB1R in the EPN. a, The procedures to measure the gray values of immunoreactivities for SP and CB1R. The dual-label image (1) is split into two singe-channel images (2), which are overlaid with a grid (3). The frames to be analyzed are selected according to the syst... |
PMC9410772_F4_384210.jpg | What is the dominant medical problem in this image? | a–h, CLSM images of triple-labeled immunohistochemistry for CB1R, GAD, and vGluT2 in the CA1 region of the hippocampus (a, c, e, g) and lSP/hCB1R-immunoreactive area of the EPN (b, d, f, h). The pseudocolor images (a, b) consist of CB1R (red), GAD (green), and vGluT2 (blue) immunoreactivities, each displayed in the bot... |
PMC9410772_F4_384205.jpg | What is the principal component of this image? | a–h, CLSM images of triple-labeled immunohistochemistry for CB1R, GAD, and vGluT2 in the CA1 region of the hippocampus (a, c, e, g) and lSP/hCB1R-immunoreactive area of the EPN (b, d, f, h). The pseudocolor images (a, b) consist of CB1R (red), GAD (green), and vGluT2 (blue) immunoreactivities, each displayed in the bot... |
PMC9410772_F4_384208.jpg | What object or scene is depicted here? | a–h, CLSM images of triple-labeled immunohistochemistry for CB1R, GAD, and vGluT2 in the CA1 region of the hippocampus (a, c, e, g) and lSP/hCB1R-immunoreactive area of the EPN (b, d, f, h). The pseudocolor images (a, b) consist of CB1R (red), GAD (green), and vGluT2 (blue) immunoreactivities, each displayed in the bot... |
PMC9410772_F4_384211.jpg | What is the core subject represented in this visual? | a–h, CLSM images of triple-labeled immunohistochemistry for CB1R, GAD, and vGluT2 in the CA1 region of the hippocampus (a, c, e, g) and lSP/hCB1R-immunoreactive area of the EPN (b, d, f, h). The pseudocolor images (a, b) consist of CB1R (red), GAD (green), and vGluT2 (blue) immunoreactivities, each displayed in the bot... |
PMC9410772_F4_384204.jpg | What is the central feature of this picture? | a–h, CLSM images of triple-labeled immunohistochemistry for CB1R, GAD, and vGluT2 in the CA1 region of the hippocampus (a, c, e, g) and lSP/hCB1R-immunoreactive area of the EPN (b, d, f, h). The pseudocolor images (a, b) consist of CB1R (red), GAD (green), and vGluT2 (blue) immunoreactivities, each displayed in the bot... |
PMC9410772_F4_384207.jpg | What key item or scene is captured in this photo? | a–h, CLSM images of triple-labeled immunohistochemistry for CB1R, GAD, and vGluT2 in the CA1 region of the hippocampus (a, c, e, g) and lSP/hCB1R-immunoreactive area of the EPN (b, d, f, h). The pseudocolor images (a, b) consist of CB1R (red), GAD (green), and vGluT2 (blue) immunoreactivities, each displayed in the bot... |
PMC9410772_F5_384212.jpg | What's the most prominent thing you notice in this picture? | a–d, Electron micrographs illustrating the immunohistochemical localization of CB1R in the EPN. CB1R-immunoreactive elements labeled by DAB are located in preterminal axons (a, b, arrows) and axon terminals (t). The accumulation of labeled axons and axon terminals shown in c is consistent with diffuse, intense labeling... |
PMC9410772_F5_384214.jpg | What key item or scene is captured in this photo? | a–d, Electron micrographs illustrating the immunohistochemical localization of CB1R in the EPN. CB1R-immunoreactive elements labeled by DAB are located in preterminal axons (a, b, arrows) and axon terminals (t). The accumulation of labeled axons and axon terminals shown in c is consistent with diffuse, intense labeling... |
PMC9410772_F5_384213.jpg | What is the focal point of this photograph? | a–d, Electron micrographs illustrating the immunohistochemical localization of CB1R in the EPN. CB1R-immunoreactive elements labeled by DAB are located in preterminal axons (a, b, arrows) and axon terminals (t). The accumulation of labeled axons and axon terminals shown in c is consistent with diffuse, intense labeling... |
PMC9410772_F5_384215.jpg | Describe the main subject of this image. | a–d, Electron micrographs illustrating the immunohistochemical localization of CB1R in the EPN. CB1R-immunoreactive elements labeled by DAB are located in preterminal axons (a, b, arrows) and axon terminals (t). The accumulation of labeled axons and axon terminals shown in c is consistent with diffuse, intense labeling... |
PMC9410777_fig2_384222.jpg | Describe the main subject of this image. | The inflammatory manifestations were evaluated with H&E staining. The representative images of the rectus femoris of the left hindlimb of the experimental group and the control group were treated for 7 and 14 days. Inflammatory cell infiltration (↙); Muscle fiber swelling (∗). Magnifications: ×400, Scale bar = 60 μm. C... |
PMC9410777_fig2_384216.jpg | What is the main focus of this visual representation? | The inflammatory manifestations were evaluated with H&E staining. The representative images of the rectus femoris of the left hindlimb of the experimental group and the control group were treated for 7 and 14 days. Inflammatory cell infiltration (↙); Muscle fiber swelling (∗). Magnifications: ×400, Scale bar = 60 μm. C... |
PMC9410777_fig2_384217.jpg | What is the principal component of this image? | The inflammatory manifestations were evaluated with H&E staining. The representative images of the rectus femoris of the left hindlimb of the experimental group and the control group were treated for 7 and 14 days. Inflammatory cell infiltration (↙); Muscle fiber swelling (∗). Magnifications: ×400, Scale bar = 60 μm. C... |
PMC9410777_fig2_384223.jpg | What is the focal point of this photograph? | The inflammatory manifestations were evaluated with H&E staining. The representative images of the rectus femoris of the left hindlimb of the experimental group and the control group were treated for 7 and 14 days. Inflammatory cell infiltration (↙); Muscle fiber swelling (∗). Magnifications: ×400, Scale bar = 60 μm. C... |
PMC9410777_fig2_384218.jpg | What can you see in this picture? | The inflammatory manifestations were evaluated with H&E staining. The representative images of the rectus femoris of the left hindlimb of the experimental group and the control group were treated for 7 and 14 days. Inflammatory cell infiltration (↙); Muscle fiber swelling (∗). Magnifications: ×400, Scale bar = 60 μm. C... |
PMC9410816_fig3_384234.jpg | What's the most prominent thing you notice in this picture? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384227.jpg | What is the focal point of this photograph? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384235.jpg | What is the focal point of this photograph? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384231.jpg | What key item or scene is captured in this photo? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384228.jpg | Can you identify the primary element in this image? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384226.jpg | What's the most prominent thing you notice in this picture? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384233.jpg | What stands out most in this visual? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384225.jpg | What is the core subject represented in this visual? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384236.jpg | What is the focal point of this photograph? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384232.jpg | What is the principal component of this image? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410816_fig3_384229.jpg | What key item or scene is captured in this photo? | Comparison of imaging findings in a patient who was diagnosed with advanced esophageal cancer with lung and liver metastases at the first visit and received sintilimab-based regimens. (a, c, e–g) Imaging findings before treatment with 2 cycles of sintilimab plus albumin-bound paclitaxel, nedaplatin, and palliative radi... |
PMC9410822_fig1_384238.jpg | What is the core subject represented in this visual? | Immunohistochemical color development results. |
PMC9410822_fig1_384240.jpg | Can you identify the primary element in this image? | Immunohistochemical color development results. |
PMC9410822_fig1_384239.jpg | What object or scene is depicted here? | Immunohistochemical color development results. |
PMC9410826_fig1_384245.jpg | What is the main focus of this visual representation? | Representative images of good recovery after operation using unilateral external fixator combined with lateral auxiliary frame. The X-ray images at preoperation (a, b), after operation (c, d), postoperative 3 months (e, f), postoperative 6 months (g, h), and 12 months (i, j), respectively. |
PMC9410826_fig1_384241.jpg | What is being portrayed in this visual content? | Representative images of good recovery after operation using unilateral external fixator combined with lateral auxiliary frame. The X-ray images at preoperation (a, b), after operation (c, d), postoperative 3 months (e, f), postoperative 6 months (g, h), and 12 months (i, j), respectively. |
PMC9410826_fig1_384242.jpg | What is the core subject represented in this visual? | Representative images of good recovery after operation using unilateral external fixator combined with lateral auxiliary frame. The X-ray images at preoperation (a, b), after operation (c, d), postoperative 3 months (e, f), postoperative 6 months (g, h), and 12 months (i, j), respectively. |
PMC9410835_fig4_384256.jpg | What can you see in this picture? | Electron micrographs of choriocapillaris vessels. (a) From a rat eye which was fixed immediately after enucleation: regular endothelium with fenestrations (marked by black arrows). There are a few unsuspicious small projections to the vessel lumen which are indicated by a black arrowhead (same labels used also in the f... |
PMC9410835_fig4_384254.jpg | What key item or scene is captured in this photo? | Electron micrographs of choriocapillaris vessels. (a) From a rat eye which was fixed immediately after enucleation: regular endothelium with fenestrations (marked by black arrows). There are a few unsuspicious small projections to the vessel lumen which are indicated by a black arrowhead (same labels used also in the f... |
PMC9410835_fig4_384260.jpg | What is shown in this image? | Electron micrographs of choriocapillaris vessels. (a) From a rat eye which was fixed immediately after enucleation: regular endothelium with fenestrations (marked by black arrows). There are a few unsuspicious small projections to the vessel lumen which are indicated by a black arrowhead (same labels used also in the f... |
PMC9410835_fig4_384257.jpg | What does this image primarily show? | Electron micrographs of choriocapillaris vessels. (a) From a rat eye which was fixed immediately after enucleation: regular endothelium with fenestrations (marked by black arrows). There are a few unsuspicious small projections to the vessel lumen which are indicated by a black arrowhead (same labels used also in the f... |
PMC9410835_fig4_384258.jpg | Can you identify the primary element in this image? | Electron micrographs of choriocapillaris vessels. (a) From a rat eye which was fixed immediately after enucleation: regular endothelium with fenestrations (marked by black arrows). There are a few unsuspicious small projections to the vessel lumen which are indicated by a black arrowhead (same labels used also in the f... |
PMC9410835_fig4_384259.jpg | What does this image primarily show? | Electron micrographs of choriocapillaris vessels. (a) From a rat eye which was fixed immediately after enucleation: regular endothelium with fenestrations (marked by black arrows). There are a few unsuspicious small projections to the vessel lumen which are indicated by a black arrowhead (same labels used also in the f... |
PMC9410835_fig5_384252.jpg | What stands out most in this visual? | Electron micrographs of representative choriocapillaris vessels. (a) From rat eyes which were intravitreally injected with PEDF after enucleation and was incubated for 14 h at 4°C: only small projections and normal vessel lumen (∗). (b) From an eyes which were incubated for 14 h at 4°C: here the lumen of the capillarie... |
PMC9410835_fig5_384251.jpg | What can you see in this picture? | Electron micrographs of representative choriocapillaris vessels. (a) From rat eyes which were intravitreally injected with PEDF after enucleation and was incubated for 14 h at 4°C: only small projections and normal vessel lumen (∗). (b) From an eyes which were incubated for 14 h at 4°C: here the lumen of the capillarie... |
PMC9410835_fig5_384249.jpg | What's the most prominent thing you notice in this picture? | Electron micrographs of representative choriocapillaris vessels. (a) From rat eyes which were intravitreally injected with PEDF after enucleation and was incubated for 14 h at 4°C: only small projections and normal vessel lumen (∗). (b) From an eyes which were incubated for 14 h at 4°C: here the lumen of the capillarie... |
PMC9410835_fig5_384248.jpg | What is the dominant medical problem in this image? | Electron micrographs of representative choriocapillaris vessels. (a) From rat eyes which were intravitreally injected with PEDF after enucleation and was incubated for 14 h at 4°C: only small projections and normal vessel lumen (∗). (b) From an eyes which were incubated for 14 h at 4°C: here the lumen of the capillarie... |
PMC9410842_fig3_384263.jpg | What can you see in this picture? | Imaging and targeting pancreatic orthotopic tumor of group A. (a) B-mode ultrasound imaging of tumors; (b) NIRF imaging of tumors; and (c) NIRF imaging of organs. The lungs, heart, kidney, spleen, tumor in situ, and inguinal lymph node are from left to right in the first row. The testes and spermaduct, and liver are in... |
PMC9410842_fig3_384265.jpg | What is the focal point of this photograph? | Imaging and targeting pancreatic orthotopic tumor of group A. (a) B-mode ultrasound imaging of tumors; (b) NIRF imaging of tumors; and (c) NIRF imaging of organs. The lungs, heart, kidney, spleen, tumor in situ, and inguinal lymph node are from left to right in the first row. The testes and spermaduct, and liver are in... |
PMC9410842_fig3_384267.jpg | What is the dominant medical problem in this image? | Imaging and targeting pancreatic orthotopic tumor of group A. (a) B-mode ultrasound imaging of tumors; (b) NIRF imaging of tumors; and (c) NIRF imaging of organs. The lungs, heart, kidney, spleen, tumor in situ, and inguinal lymph node are from left to right in the first row. The testes and spermaduct, and liver are in... |
PMC9410842_fig3_384262.jpg | What stands out most in this visual? | Imaging and targeting pancreatic orthotopic tumor of group A. (a) B-mode ultrasound imaging of tumors; (b) NIRF imaging of tumors; and (c) NIRF imaging of organs. The lungs, heart, kidney, spleen, tumor in situ, and inguinal lymph node are from left to right in the first row. The testes and spermaduct, and liver are in... |
PMC9410867_fig2_384273.jpg | What is the focal point of this photograph? | The procedures of preprocessing: (a) the original CT image, (b) the binary bone region mask after thresholding at 180 HU, (c) the mask after removing small connected components, (d) the mask after morphological dilation, (e) the mask after extracting the largest connected component, (f) the extracted bone regions by ap... |
PMC9410867_fig2_384268.jpg | What key item or scene is captured in this photo? | The procedures of preprocessing: (a) the original CT image, (b) the binary bone region mask after thresholding at 180 HU, (c) the mask after removing small connected components, (d) the mask after morphological dilation, (e) the mask after extracting the largest connected component, (f) the extracted bone regions by ap... |
PMC9410867_fig2_384271.jpg | Describe the main subject of this image. | The procedures of preprocessing: (a) the original CT image, (b) the binary bone region mask after thresholding at 180 HU, (c) the mask after removing small connected components, (d) the mask after morphological dilation, (e) the mask after extracting the largest connected component, (f) the extracted bone regions by ap... |
PMC9410867_fig2_384270.jpg | What is the main focus of this visual representation? | The procedures of preprocessing: (a) the original CT image, (b) the binary bone region mask after thresholding at 180 HU, (c) the mask after removing small connected components, (d) the mask after morphological dilation, (e) the mask after extracting the largest connected component, (f) the extracted bone regions by ap... |
PMC9410867_fig2_384272.jpg | Describe the main subject of this image. | The procedures of preprocessing: (a) the original CT image, (b) the binary bone region mask after thresholding at 180 HU, (c) the mask after removing small connected components, (d) the mask after morphological dilation, (e) the mask after extracting the largest connected component, (f) the extracted bone regions by ap... |
PMC9410924_fig4_384275.jpg | What is the focal point of this photograph? | Comparison of ultrasound images before and after denoising. (a) The original image and (b) the denoised image. |
PMC9410924_fig4_384274.jpg | What is the main focus of this visual representation? | Comparison of ultrasound images before and after denoising. (a) The original image and (b) the denoised image. |
PMC9410946_fig1_384279.jpg | What's the most prominent thing you notice in this picture? | The brightness of the left lower lobe increased with a range of about 32.3 mm × 45.6 mm × 62.8 mm. The inner lung texture was sparse, with bronchovascular bundle running, no clear envelope at the edge, and no clear abnormal aortic blood supply. The remaining two lung fields were clear, lung texture was regular, and no ... |
PMC9410946_fig1_384280.jpg | Can you identify the primary element in this image? | The brightness of the left lower lobe increased with a range of about 32.3 mm × 45.6 mm × 62.8 mm. The inner lung texture was sparse, with bronchovascular bundle running, no clear envelope at the edge, and no clear abnormal aortic blood supply. The remaining two lung fields were clear, lung texture was regular, and no ... |
PMC9410946_fig1_384277.jpg | What is being portrayed in this visual content? | The brightness of the left lower lobe increased with a range of about 32.3 mm × 45.6 mm × 62.8 mm. The inner lung texture was sparse, with bronchovascular bundle running, no clear envelope at the edge, and no clear abnormal aortic blood supply. The remaining two lung fields were clear, lung texture was regular, and no ... |
PMC9410946_fig1_384278.jpg | What is the central feature of this picture? | The brightness of the left lower lobe increased with a range of about 32.3 mm × 45.6 mm × 62.8 mm. The inner lung texture was sparse, with bronchovascular bundle running, no clear envelope at the edge, and no clear abnormal aortic blood supply. The remaining two lung fields were clear, lung texture was regular, and no ... |
PMC9410952_fig1_384282.jpg | What's the most prominent thing you notice in this picture? | The expression of matrix metalloproteinase 15 (MMP15) in the cytoplasm of positive sentinel lymph nodes (SLNs); the cells were magnified 400 times. (a) The expression of MMP15 was positive. (b) The expression of MMP15 was negative. |
PMC9410952_fig1_384281.jpg | What is the core subject represented in this visual? | The expression of matrix metalloproteinase 15 (MMP15) in the cytoplasm of positive sentinel lymph nodes (SLNs); the cells were magnified 400 times. (a) The expression of MMP15 was positive. (b) The expression of MMP15 was negative. |
PMC9410978_fig1_384285.jpg | What does this image primarily show? | Pulmonary hemorrhage after CT-guided core needle biopsy. |
PMC9410978_fig1_384284.jpg | What key item or scene is captured in this photo? | Pulmonary hemorrhage after CT-guided core needle biopsy. |
PMC9410984_fig1_384286.jpg | What is the dominant medical problem in this image? | Case 1. Apical four-chamber view of left ventricle with Simpson disk summation method showing increased left ventricular end diastolic volume and diameter. Telemetry strip showing polymorphic ventricular fibrillation rhythm. |
PMC9410984_fig1_384287.jpg | What stands out most in this visual? | Case 1. Apical four-chamber view of left ventricle with Simpson disk summation method showing increased left ventricular end diastolic volume and diameter. Telemetry strip showing polymorphic ventricular fibrillation rhythm. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.